Lipocine (LPCN) Accumulated Expenses (2012 - 2025)
Lipocine (LPCN) posted Accumulated Expenses of $1.24 million for Q4 2025, up 34.2% from $921,240 a year earlier and up 64.9% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Accumulated Expenses (2012 - 2025) Analysis & Trends
Since Q4 2012, Lipocine has reported Accumulated Expenses for 51 quarters.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
- In prior years, Lipocine's Accumulated Expenses was $921,240 in FY2024 (-24.4%), $1.22 million in FY2023 (+13.1%), $1.08 million in FY2022 (+6.0%) and $1.02 million in FY2021 (-38.5%).
- The Q4 2025 figure stands as the highest quarterly Accumulated Expenses since Q3 2024.
- On a year-over-year basis, Accumulated Expenses increased in two of the last eight quarters, with an average decline of 15.1%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2021, with growth of 103.8%; the weakest was Q1 2022, with a decline of 62.3%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $749,667 (Q3 2025), $685,779 (Q2 2025) and $619,410 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 749,667.00 |
| Jun 30, 2025 | 685,779.00 |
| Mar 31, 2025 | 619,410.00 |
| Dec 31, 2024 | 921,240.00 |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 761,465.00 |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 880,850.00 |
| Jun 30, 2022 | 899,301.00 |
| Mar 31, 2022 | 567,901.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Mar 31, 2021 | 1.50 Mn |
API Access
Lipocine Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();